Health Catalyst, Inc. (HCAT) Free cash flow 2017–2025
Health Catalyst, Inc. (HCAT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$237,000FY2025 · since FY2017: -$39.3M → -$237,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$237,000 | -101.8% |
| FY2024 | $12.9M | +137.7% |
| FY2023 | -$34.3M | +8.3% |
| FY2022 | -$37.4M | -11.5% |
| FY2021 | -$33.6M | +1.0% |
| FY2020 | -$33.9M | +0.8% |
| FY2019 | -$34.2M | +19.3% |
| FY2018 | -$42.4M | -7.8% |
| FY2017 | -$39.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HCAT financial trends
HCAT RevenueHCAT Net incomeHCAT Net marginHCAT Gross profitHCAT Gross marginHCAT Operating incomeHCAT Operating marginHCAT Operating cash flowHCAT Capital expendituresHCAT Return on equityHCAT Stock buybacksHCAT Dividends paidHCAT Total assetsHCAT Total liabilitiesHCAT Shareholders’ equityHCAT overview →